English | Español
Patient Daily | Dec 9, 2025

Protego Biopharma raises $130M series B for pivotal amyloidosis drug trial
Patient Daily | Dec 9, 2025

Building next-generation biologics relies on AI integration and automation advances
Patient Daily | Dec 9, 2025

FDA extends review period for Ascendis Pharma's dwarfism drug TransCon CNP
Patient Daily | Dec 9, 2025

Regeneron partners with Tessera Therapeutics on gene editing therapy for AATD
Patient Daily | Dec 9, 2025

FDA’s advanced manufacturing designation may ease mid-development process changes for cell therapies
Patient Daily | Dec 9, 2025

Lilly reduces Zepbound prices amid ongoing competition with Novo Nordisk
Patient Daily | Dec 9, 2025

FDA official links child deaths to COVID-19 vaccines and proposes stricter review process
Patient Daily | Dec 9, 2025

Study finds rising rates of adolescent noise-induced hearing damage by age eighteen

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
L. R. Alvarez | Jul 30, 2026

TPA's Ross Marchand on 340B: 'Taxpayers are picking up the tab for the program's many failures and mission creep'
+ Regulatory
J. R. Bair | Jul 28, 2026

Employers for Hospital Accountability: 'Participating hospitals are stockpiling far more assets than similar non-340B hospitals'
+ Pharmaceuticals
Patient Daily | Jul 30, 2026

Jefferies analysts say Daiichi Sankyo’s pipeline lags as cash flow nears peak